[Clinical value of liquifying drugs of bronchial secretions].
D000470:Alkaloids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001285:Atropine / Q000627:therapeutic use; D001980:Bronchi / Q000378:metabolism; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D004573:Electrolytes / Q000627:therapeutic use; D057487:Enzyme Therapy; D005100:Expectorants / Q000627:therapeutic use; D006801:Humans; D009093:Mucus / Q000032:analysis; D010277:Parasympathomimetics / Q000627:therapeutic use; D013183:Sputum / Q000032:analysis / Q000187:drug effects*; D014783:Viscosity
D000470:Alkaloids; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000697:Central Nervous System Stimulants; D004573:Electrolytes; D005100:Expectorants; D010277:Parasympathomimetics; D001285:Atropine
Intérêt clinique des médications fluidifiantes des sécrétions bronchiques.